Minnesota to resume umbilical cord blood donations

  • Article by: JEREMY OLSON , Star Tribune
  • Updated: November 18, 2013 - 10:08 AM

The U is finalizing a deal to allow new mothers to donate umbilical cord blood for transplants and stem cell research.

 

Donating umbilical cord blood — a rich source of lifesaving stem cells — hasn’t been an option for new mothers in Minnesota for years.

But a new partnership between the University of Minnesota and the St. Louis Cord Blood Bank in Missouri could restore that chance — and accelerate research at the U, a pioneering center for cord blood transplants and stem cell research.

Leaders of the two organizations are meeting Tuesday to finalize a deal allowing the university Medical Center to collect cord blood after childbirth and send it to St. Louis to be stored and matched to patients who need it.

Transplants of the regenerative stem cells in cord blood help fight cancers such as leukemia by killing the cancer cells and rebuilding immune systems that are wiped away by chemotherapy and radiation.

The absence of local donation hasn’t hindered Minnesotans in receiving transplants from a national donor pool, but it has hampered the pace of research at the U, where Dr. John Wagner performed the world’s first cord blood transplant for leukemia in 1990.

And it is something of an embarrassment, considering the U’s prominence in the specialty and the fact that Be The Match, the organization that matches cord blood to patients, is based in Minneapolis.

“Fact is, this is the world’s largest cord blood transplant program,” said Dr. Jeff McCullough, a U pathologist and specialist in transfusion medicine. “To not even be collecting here for potential transplants? We should be able to do better than that.”

Researchers benefit from local collections because they can receive cord blood units that are ruled unsuitable for transplant. Lacking that, Wagner’s team has had a limited supply of cord blood for research and has paid a premium to buy discarded units from other states.

U researchers are trying, among other things, to determine if cord blood medicine can move beyond rare cancers and become effective treatments for common diseases such as diabetes. They also are studying ways to coax cord blood stem cells to work faster, especially for cancer patients at risk of fatal infections while their immune systems recover.

Cord blood is the lingering blood in the umbilical cord and placenta after childbirth. Donation involves draining that blood after the cord is clamped and severed from the newborn.

While cord blood isn’t the only source of stem cells, it has advantages over stem cells that are commonly obtained from adult bone marrow donors.

‘It saved my life’

Phillip Englund received a stem cell transplant at the U Amplatz Children’s Hospital 80 days ago, at the ideal juncture of his chemotherapy and radiation, because a cord blood unit was immediately available.

On Friday, the 20-year-old from Grand Rapids, Minn., learned he is on track to go home after months in the Minneapolis hospital to fight leukemia, and that he can think about resuming college.

“It saved my life,” he said. “As weird as it is [to receive stem cells from umbilical cord blood], it was what I needed.”

The American Red Cross used to bank cord blood from hospitals in Minneapolis, Coon Rapids and Mankato but got out of the business six years ago.

McCullough directed the Red Cross bank at the time, and tried unsuccessfully to get the U to take it over. Other efforts to maintain cord blood banking in Minnesota fell apart when federal grants were steered toward states with greater demographic diversity, because of the need for cord blood from ethnic and racial minorities.

  • related content

  • Phillip Englund was examined by Dr. Heather Stefanski after he received a cord blood transfusion at the U.

  • get related content delivered to your inbox

  • manage my email subscriptions

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

 
Close